第 4 回左心耳閉塞研究 (LAAOS-4)
第 4 回左心耳閉塞研究 (LAAOS-4)
LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
調査の概要
詳細な説明
LAAOS-4 is a multicentre, prospective, open-label, randomized controlled trial with blinded assessment of endpoints (PROBE) to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Program Director
- 電話番号:905-521-2100
- メール:LAAOS-4@phri.ca
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35243
- 引きこもった
- Affinity Hospital dba Grandview Medical Center
-
-
Arkansas
-
Jonesboro、Arkansas、アメリカ、72401
- 募集
- Arrhythmia Research Group
-
主任研究者:
- Devi Nair, MD
-
-
California
-
Fountain Valley、California、アメリカ、92708
- 募集
- Memorial Health Services
-
主任研究者:
- Nikhil Warrier, MD
-
Loma Linda、California、アメリカ、92354
- 引きこもった
- Loma Linda University Health
-
Los Angeles、California、アメリカ、90048
- 募集
- Cedars-Sinai Medical Center
-
主任研究者:
- Tarun Chakravarty, MD
-
Pasadena、California、アメリカ、91101
- 募集
- Southern California Permanente Medical Group
-
主任研究者:
- Bahram Khadivi, MD
-
Sacramento、California、アメリカ、95816
- 募集
- Sutter Valley Hospitals dba Sutter Institute for Medical Research
-
主任研究者:
- David Roberts, MD
-
-
Delaware
-
Wilmington、Delaware、アメリカ、19803
- 募集
- Christiana Care Health Services, Inc.
-
主任研究者:
- Neil Wimmer, MD
-
-
Florida
-
Atlantis、Florida、アメリカ、33462
- 引きこもった
- JFK Medical Center Limited Partnership d/b/a HCA Florida JFK Hospital
-
Jacksonville、Florida、アメリカ、32204
- 引きこもった
- St. Vincent's Health System
-
Largo、Florida、アメリカ、33770
- 引きこもった
- Largo Medical Center, Inc. d/b/a HCA Florida Largo Medical Center
-
Ocala、Florida、アメリカ、34471
- 引きこもった
- HCA Florida Ocala Hospital
-
Tampa、Florida、アメリカ、33620
- 募集
- The University of South Florida
-
主任研究者:
- Bibhu Mohanty, MD
-
-
Georgia
-
Atlanta、Georgia、アメリカ、30322
- 募集
- Emory University
-
主任研究者:
- David De Lurgio, MD
-
-
Idaho
-
Boise、Idaho、アメリカ、83712
- 募集
- St Luke's Regional Medical Center, Ltd
-
主任研究者:
- Marcos Daccarett, MD
-
Coeur d'Alene、Idaho、アメリカ、83814
- 募集
- Kootenai Health Inc.
-
主任研究者:
- Michele Murphy-Cook, MD
-
-
Illinois
-
Evanston、Illinois、アメリカ、60208
- 募集
- Northwestern University
-
主任研究者:
- Albert Lin, MD
-
Rock Island、Illinois、アメリカ、61201
- 募集
- Cardiovascular Medicine, PLLC and Unity Point Trinity Rock Island
-
主任研究者:
- Mark Shen, MD
-
-
Indiana
-
Indianapolis、Indiana、アメリカ、46256
- 募集
- Community Health Network Inc.
-
主任研究者:
- Krishna Malineni, MD
-
-
Iowa
-
West Des Moines、Iowa、アメリカ、50266
- 募集
- MercyOne Iowa Heart Center
-
主任研究者:
- Pitayadet Jumrussirikul, MD
-
-
Kansas
-
Kansas City、Kansas、アメリカ、66160
- 募集
- University of Kansas Medical Center Research Institute, Inc.
-
主任研究者:
- Madhu Reddy, MD
-
-
Kentucky
-
Lexington、Kentucky、アメリカ、40503
- 募集
- Babtist Health Lexington
-
主任研究者:
- Gery Tomassoni, MD
-
-
Louisiana
-
New Orleans、Louisiana、アメリカ、70121
- 募集
- Ochsner Clinic Foundation
-
主任研究者:
- Richard Zweifler, MD
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21201
- 募集
- University of Maryland Baltimore
-
主任研究者:
- Seemant Chaturvedi, MD
-
-
Massachusetts
-
Burlington、Massachusetts、アメリカ、01805
- 募集
- Lahey Clinic Inc.
-
主任研究者:
- Bruce Hook, MD
-
-
Michigan
-
Ann Arbor、Michigan、アメリカ、48109
- 募集
- University of Michigan
-
主任研究者:
- Hakan Oral, MD
-
Detroit、Michigan、アメリカ、48202
- 募集
- Henry Ford Health System
-
主任研究者:
- Amir Kaki, MD
-
主任研究者:
- Waddah Maskoun, MD
-
-
Minnesota
-
Rochester、Minnesota、アメリカ、55905
- 募集
- Mayo Clinic
-
主任研究者:
- Eugene L. Scharf, MD
-
-
Missouri
-
St Louis、Missouri、アメリカ、63103
- 募集
- St. Louis University,
-
主任研究者:
- Div Verma, MD
-
-
New Jersey
-
Hackensack、New Jersey、アメリカ、07601
- 募集
- Hackensack University Medical Center
-
主任研究者:
- Taya Glotzer, MD
-
-
New Mexico
-
Albuquerque、New Mexico、アメリカ、87106
- 募集
- Presbyterian Healthcare Services d.b.a. Presbyterian Heart Group
-
主任研究者:
- Sharif Halim, MD
-
-
New York
-
Manhasset、New York、アメリカ、11030
- 引きこもった
- The Feinstein Institutes for Medical Research
-
New York、New York、アメリカ、10065
- 募集
- Cornell University for and on behalf of its Joan & Sanford I. Weill Medical College and The New York Presbyterian Hospital
-
主任研究者:
- Christopher Liu, MD
-
New York、New York、アメリカ、10065
- 引きこもった
- NYU Grossman School of Medicine
-
-
North Carolina
-
Asheville、North Carolina、アメリカ、28801
- 募集
- Mission Hospital HCA
-
主任研究者:
- John Rhyner, MD
-
-
Ohio
-
Canton、Ohio、アメリカ、44710
- 募集
- Aultman Hospital
-
主任研究者:
- Firas Hamdan, MD
-
Cincinnati、Ohio、アメリカ、45221
- 募集
- University of Cincinnati
-
主任研究者:
- Srinivas Rajsheker, MD
-
Cincinnati、Ohio、アメリカ、45202
- 募集
- TriHealth Inc.
-
主任研究者:
- Gaurang Gandhi, MD
-
Cleveland、Ohio、アメリカ、44195
- 募集
- Cleveland Clinic
-
主任研究者:
- Oussama Wazni, MD
-
-
Oklahoma
-
Tulsa、Oklahoma、アメリカ、74136
- 募集
- Saint Francis Hospital
-
主任研究者:
- Tom Hu, MD
-
-
Pennsylvania
-
Hershey、Pennsylvania、アメリカ、17033
- 募集
- The Pennsylvania State University and The Milton S. Hershey Medical Center
-
主任研究者:
- Soraya Samii, MD
-
Philadelphia、Pennsylvania、アメリカ、19104
- 募集
- The Trustees of the University of Pennsylvania
-
主任研究者:
- Steven Messe, MD
-
Pittsburgh、Pennsylvania、アメリカ、15213
- 募集
- University of Pittsburgh Medical Center (UPMC) Presbyterian Heart and Vascular Institute
-
主任研究者:
- Sandeep Jain, MD
-
-
Rhode Island
-
Providence、Rhode Island、アメリカ、02903
- 募集
- Rhode Island Hospital
-
主任研究者:
- Ana-Lucia Garcia-Guarniz, MD
-
-
Tennessee
-
Brentwood、Tennessee、アメリカ、37027
- 引きこもった
- Glanecare, Inc. d/b/a HCA Florida Brandon Hospital
-
Memphis、Tennessee、アメリカ、38163
- 募集
- The University of Tennessee
-
主任研究者:
- Balaji Krishnaiah, MD
-
-
Texas
-
Austin、Texas、アメリカ、78705
- 引きこもった
- Texas Cardiac Arrhythmia Research Foundation
-
Dallas、Texas、アメリカ、75204
- 募集
- Baylor Research Institute
-
主任研究者:
- Praveen Rao, MD
-
The Woodlands、Texas、アメリカ、77380
- 引きこもった
- Heart Rhythm Associates
-
Tyler、Texas、アメリカ、75701-2263
- 募集
- CHRISTUS Northeast Texas Health System
-
主任研究者:
- Stanislav Weiner, MD
-
-
Virginia
-
Charlottesville、Virginia、アメリカ、22903
- 募集
- The Rector and Visitors of the University of Virginia
-
主任研究者:
- Rohit Malhotra, MD
-
-
Washington
-
Tacoma、Washington、アメリカ、98405
- 募集
- CommonSpirit Health Research Institute
-
主任研究者:
- Nasir Shariff, MD
-
-
Wisconsin
-
Milwaukee、Wisconsin、アメリカ、53226
- 募集
- The Medical College of Wisconsin
-
主任研究者:
- James Oujiri, MD
-
-
-
-
-
Liverpool、イギリス、L14 3PE
- 募集
- Liverpool Heart and Chest Hospital NHS Foundation Trust
-
主任研究者:
- Dhiraj Gupta, MD
-
Southampton、イギリス、SO16 6YD
- 募集
- University Hospital Southampton NHS Foundation Trust
-
主任研究者:
- John Paisey, MD
-
-
Leicestershire
-
Leicester、Leicestershire、イギリス、LE1 5WW
- 募集
- University Hospitals of Leicester NHS Trust
-
主任研究者:
- Jan Kovac, Prof., MD
-
-
Nottinghamshire
-
Nottingham、Nottinghamshire、イギリス、NG5 1PB
- 募集
- Nottingham University Hospital NHS Trust
-
主任研究者:
- Ashan Gunarathne, MD
-
-
Oxfordshire
-
Oxford、Oxfordshire、イギリス、OX3 9DU
- 募集
- Oxford University Hospitals NHS Foundation Trust
-
主任研究者:
- Tim Betts, MD
-
-
West Midlands
-
Coventry、West Midlands、イギリス、CV2 2DX
- 募集
- University Hospitals Coventry and Warwickshire
-
主任研究者:
- Sandeep Panikker, MD
-
-
West Sussex
-
Worthing、West Sussex、イギリス、BN11 2DH
- 募集
- University Hospitals Sussex NHS Trust
-
主任研究者:
- David Hildick-Smith, MD
-
-
-
-
-
Brescia、イタリア、25124
- 募集
- Fondazione Poliambulanza Istituto Ospedaliero
-
主任研究者:
- Diego Maffeo, MD
-
Sassari、イタリア、07100
- 募集
- Azienda Ospedaliero Universitaria Sassari
-
主任研究者:
- Gavino Casu, Prof., MD
-
-
-
-
North Brabant
-
Eindhoven、North Brabant、オランダ、5623EJ
- 募集
- Stichting Catharina Ziekenhuis
-
主任研究者:
- Pepijn van der Voort, MD
-
-
Utrecht
-
Nieuwegein、Utrecht、オランダ、3435CM
- 募集
- St. Antonius Hospital
-
主任研究者:
- Lucas Boersma, Prof., MD
-
-
-
-
Alberta
-
Calgary、Alberta、カナダ、T2N 1N4
- 募集
- University of Calgary
-
主任研究者:
- Stephen Wilton, MD
-
-
British Columbia
-
Vancouver、British Columbia、カナダ、V5Z 1M9
- 募集
- Vancouver Coastal Health Authority
-
主任研究者:
- Jason Andrade, MD
-
-
Manitoba
-
Winnipeg、Manitoba、カナダ、R2H 2A6
- 募集
- St. Boniface Hospital Inc.
-
主任研究者:
- Malek Kass, MD
-
-
Ontario
-
Burlington、Ontario、カナダ、L7M 1K9
- 募集
- Circulate Cardiac & Vascular Centre (CCVC)
-
主任研究者:
- Hisham Dokainish, MD
-
Cambridge、Ontario、カナダ、N1R 6V6
- 募集
- Cambridge Cardiac Care Inc.
-
主任研究者:
- A. Shekhar Pandey, MD
-
Hamilton、Ontario、カナダ、L8N 4A6
- 募集
- Research St. Joseph's - Hamilton
-
主任研究者:
- Vikas Tandon, MD
-
Hamilton、Ontario、カナダ、L8L 2X2
- 募集
- Hamilton Health Sciences Corp
-
主任研究者:
- Guy Amit, MD
-
Kitchener、Ontario、カナダ、N2M 5N6
- 募集
- Waterloo Wellington Cardiovascular Research Institute (WWCRI)
-
主任研究者:
- Umjeet Jolly, MD
-
London、Ontario、カナダ、N6A 2R5
- 募集
- Lawson Health Research Institute
-
主任研究者:
- Allan Skanes, MD
-
Newmarket、Ontario、カナダ、L2Y 2P9
- 募集
- Southlake Regional Health Centre
-
主任研究者:
- Mouhannad Sadek, MD
-
Newmarket、Ontario、カナダ、L3Y 2P6
- 募集
- Partners in Advanced Cardiac Evaluation (PACE)
-
主任研究者:
- Yaariv Khaykin, MD
-
Ottawa、Ontario、カナダ、K1Y 4W7
- 募集
- Ottawa Heart Institute Research Corp
-
主任研究者:
- Omar Abdel-Razek, MD
-
St. Catharines、Ontario、カナダ、L2S 0A9
- 募集
- Niagara Health Systems - St. Catharines
-
主任研究者:
- Nigel Tan, MD
-
St. Catharines、Ontario、カナダ、L2S 0A9
- 引きこもった
- Niagara Health System - Niagara Falls
-
Toronto、Ontario、カナダ、M4N 3M5
- 募集
- Sunnybrook Health Sciences Center
-
主任研究者:
- Sheldon Singh, MD
-
Toronto、Ontario、カナダ、M5G 2C4
- 募集
- University Health Network
-
主任研究者:
- Eric Horlick, MD
-
Toronto、Ontario、カナダ、M4N 3N1
- 募集
- Lawrence Park Cardiology
-
主任研究者:
- Eugene Crystal, MD
-
Toronto、Ontario、カナダ、M5B 1W8
- 募集
- Unity Health Toronto
-
主任研究者:
- Neil Fam, MD
-
-
Quebec
-
Montreal、Quebec、カナダ、H1T 1C8
- 募集
- Institut de Cardiologie de Montreal (ICM)
-
主任研究者:
- Reda Ibrahim, MD
-
Montreal、Quebec、カナダ、H2X OC1
- 募集
- Centre hospitalier de l'Université de Montréal
-
主任研究者:
- Jean-Marc Raymond, MD
-
Québec、Quebec、カナダ、G1V 4G5
- 募集
- Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval
-
主任研究者:
- Jean Champagne, MD
-
Sherbrooke、Quebec、カナダ、J1J 3H5
- 募集
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS)
-
主任研究者:
- Charles Dussault, MD
-
-
Saskatchewan
-
Regina、Saskatchewan、カナダ、S4P 0W5
- 募集
- Prairie Valscular Research Inc. (PVRI)
-
主任研究者:
- Payam Dehghani, MD
-
Saskatoon、Saskatchewan、カナダ、S7K 0M7
- 募集
- Saskatchewan Health Authority
-
主任研究者:
- Stephan Wardell, MD
-
-
-
-
Canton of Basel-City
-
Basel、Canton of Basel-City、スイス、4031
- 募集
- Universitätsspital Basel
-
主任研究者:
- Christian Sticherling, Prof., MD
-
-
-
-
-
Alicante、スペイン、03010
- 募集
- University General Hospital Dr. Balmis
-
主任研究者:
- Juan Miguel Ruiz Nodar, MD
-
Barcelona、スペイン、08035
- 募集
- Hospital Universitari Vall d'Hebron
-
主任研究者:
- Jaume Francisco Pascual, MD
-
Huelva、スペイン、21005
- 募集
- Hospital Universitario Juan Ramón Jiménez
-
主任研究者:
- Antonio Enrique Gómez Menchero, MD
-
León、スペイン、24071
- 募集
- Complejo Asistencial Universitario de León
-
主任研究者:
- Armando Perez de Prado, MD
-
Madrid、スペイン、28003
- 募集
- Universitario La Luz - Grupo Quirónsalud
-
主任研究者:
- Jorge Palazuelos, MD
-
Valladolid、スペイン、47003
- 募集
- Hospital Clínico Universitario de Valladolid
-
主任研究者:
- Ignacio Amat Santos, MD
-
-
Pontevedra
-
Vigo、Pontevedra、スペイン、36312
- 募集
- Hospital Álvaro Cunqueiro
-
主任研究者:
- Rodrigo Estevez Loureiro, MD
-
-
-
-
-
Copenhagen、デンマーク、2100
- 募集
- Rigshospitalet (RH)
-
主任研究者:
- Ole De Backer, MD
-
Hjørring、デンマーク、9800
- 募集
- North Denmark Regional Hospital
-
主任研究者:
- Albert Marni Joensen, MD
-
Odense C、デンマーク、4500
- 募集
- Odense Universitets Hospital
-
主任研究者:
- Mikkel Hougaard, MD
-
-
Central Jutland
-
Viborg、Central Jutland、デンマーク、8800
- 募集
- Region Hospital Viborg
-
主任研究者:
- Andi Eie Albertsen, MD
-
-
Region Midt
-
Aarhus、Region Midt、デンマーク、8200
- 募集
- Aarhus University Hospital (AUH)
-
主任研究者:
- Jens Erik Nielsen-Kudsk, MD
-
-
Region Syddanmark
-
Esbjerg、Region Syddanmark、デンマーク、6700
- 募集
- Esbjerg & Grindsted Hospital - University Hospital of Southern Denmark
-
主任研究者:
- Axel Brandes, MD
-
-
-
-
-
Berlin、ドイツ、12203
- 募集
- Charité - Universitätsmedizin Berlin
-
主任研究者:
- Carsten Skurk, MD
-
Berlin、ドイツ、10117
- 募集
- Charité Universitätsmedizin Berlin
-
主任研究者:
- Leif-Hendrik Boldt, MD
-
Hamburg、ドイツ、20246
- 募集
- Universitätsklinikum Hamburg-Eppendorf (UKE)
-
主任研究者:
- Andreas Metzner, Prof., MD
-
Hamburg、ドイツ、20099
- 募集
- Asklepios Kliniken Hamburg GmbH
-
主任研究者:
- Martin Bergmann, MD
-
主任研究者:
- Arian Sultan, MD
-
Heidelberg、ドイツ、69120
- 募集
- Universitätsklinikum Heidelberg
-
主任研究者:
- Farbod Sedaghat-Hamedani, MD
-
-
Baden-Wurttemberg
-
Karlsruhe、Baden-Wurttemberg、ドイツ、76133
- 募集
- Städtisches Klinikum Karsruhe gGmbH
-
主任研究者:
- Armin Luik, Prof., MD
-
-
Hesse
-
Darmstadt、Hesse、ドイツ、64287
- 募集
- Kardiovaskulaeres Zentrum Darmstadt
-
主任研究者:
- Jörg Honold, MD
-
Frankfurt am Main、Hesse、ドイツ、60389
- 募集
- CVC Rhein-Main GmbH
-
主任研究者:
- Horst Sievert, MD
-
Frankfurt am Main、Hesse、ドイツ、60431
- 募集
- MVZ CCB Frankfurt und Main-Taunus GbR
-
主任研究者:
- Boris Schmidt, MD
-
Frankfurt am Main、Hesse、ドイツ、60590
- 募集
- Johann Wolfgang Goethe Universität Franfurt - Universitätsklinikum Franfurt
-
主任研究者:
- Reza Wakili, MD
-
-
Mecklenburg-Vorpommern
-
Rostock、Mecklenburg-Vorpommern、ドイツ、D-18057
- 募集
- Universitätsmedizin Rostock
-
主任研究者:
- Hueseyin Ince, Prof., MD
-
-
North Rhine-Westphalia
-
Bad Oeynhausen、North Rhine-Westphalia、ドイツ、32545
- 募集
- Krankenhausbetriebsgesellschaft Bad Oeynhausen mbH
-
主任研究者:
- Werner Scholtz, MD
-
Cologne、North Rhine-Westphalia、ドイツ、50937
- 募集
- Universitätsklinikum Köln (AöR)
-
主任研究者:
- Daniel Steven, Prof., MD
-
-
Rhineland-Palatinate
-
Kaiserslautern、Rhineland-Palatinate、ドイツ、67665
- 募集
- Westpfalz-Klinikum GmbH
-
主任研究者:
- Burghard Schumacher, MD
-
-
Saxony
-
Leipzig、Saxony、ドイツ、04289
- 募集
- Herzzentrum Leipzig GmbH
-
主任研究者:
- Marcus Sandri, MD
-
Zwickau、Saxony、ドイツ、08060
- 募集
- Heinrich-Braun-Klinikum gemeinnützige GmbH
-
主任研究者:
- Holger H. Sigusch, MD
-
-
Schleswig-Holstein
-
Lübeck、Schleswig-Holstein、ドイツ、23538
- 募集
- Universitätsklinikum Schleswig - Holstein
-
主任研究者:
- Ingo Eitel, MD
-
-
Thuringia
-
Erfurt、Thuringia、ドイツ、99097
- 募集
- Katholisches Krankenhaus "St. Johann Nepomuk"
-
主任研究者:
- Henning Ebelt, MD
-
-
-
-
-
Lyon、フランス、69677
- 募集
- Hospices Civils de Lyon
-
主任研究者:
- Brahim Harbaoui, Prof., MD
-
Paris、フランス、75013
- 募集
- Hôpital Pitie Salpétrière
-
主任研究者:
- Johanne Silvain, Prof., MD
-
Paris、フランス、75018
- 募集
- Hôpital Bichat
-
主任研究者:
- Gregory Ducrocq, Prof., MD
-
Paris、フランス、75908
- 募集
- European Georges Pompidou Hospital
-
主任研究者:
- Eloi Marijon, MD
-
Paris、フランス、75014
- 募集
- Institut Médico-chirurgical Montsouris
-
主任研究者:
- Alaa Masri, MD
-
Paris、フランス、75012
- 募集
- The Fondation de l'AP-HP
-
主任研究者:
- Emmanuel Teiger, Prof., MD
-
-
Essonne
-
Massy、Essonne、フランス、91300
- 募集
- Hospital Prive Jacques Cartier
-
主任研究者:
- Phillipe Garot, MD
-
-
Indre-et-Loire
-
Tours、Indre-et-Loire、フランス、37044
- 募集
- Centre Hospitalier Régional Universitaire de Tours
-
主任研究者:
- Jean Michel Clerc, MD
-
-
Isère
-
La Tronche、Isère、フランス、38700
- 募集
- Centre Hospitalier Universitaire Grenoble-Alps
-
主任研究者:
- Pascal Defaye, Prof., MD
-
-
Moselle
-
Ars-Laquenexy、Moselle、フランス
- 募集
- CHR Metz-Thionville / Hôpital de MERCY
-
主任研究者:
- Marwan Yassine, MD
-
-
Occitanie
-
Toulouse、Occitanie、フランス、31076
- 募集
- Clinique Pasteur
-
主任研究者:
- Serge Boveda, MD
-
Toulouse、Occitanie、フランス、31076
- 募集
- SCP des Médecins Cardiologues
-
主任研究者:
- Bruno Farah, MD
-
Toulouse、Occitanie、フランス、31059
- 募集
- Centre Hospitalier Universitaire de Toulouse
-
主任研究者:
- Meyer Elbaz, Prof., MD
-
-
Pays de la Loire Region
-
Saint-Étienne-de-Montluc、Pays de la Loire Region、フランス、42055
- 募集
- CHU Saint Etienne
-
主任研究者:
- Antoine Da Costa, Prof., MD
-
-
Rhône
-
Caluire-et-Cuire、Rhône、フランス、69300
- 募集
- Infirmerie Protestante de Lyon
-
主任研究者:
- Cyril Durand, MD
-
Marseille、Rhône、フランス、13005
- 募集
- L'Assistance Publique-Hôpitaux de Marseille
-
主任研究者:
- Thomas Cuisset, MD
-
Marseille、Rhône、フランス、13009
- 募集
- Hôpital Privé Clairval
-
主任研究者:
- Alexis Mechulan, MD
-
-
Seine-Saint-Denis
-
Saint-Denis、Seine-Saint-Denis、フランス、93200
- 募集
- Centre Cardiologique due Nord
-
主任研究者:
- Antoine Lepillier, MD
-
-
-
-
-
Brussels、ベルギー、1090
- 募集
- Universitair Ziekenhuis Brussel
-
主任研究者:
- Stijn Lochy, MD
-
Liège、ベルギー、4000
- 募集
- CHR de la Citadelle
-
主任研究者:
- Jean-Manuel Herzet, MD
-
-
Antwerpen
-
Bonheiden、Antwerpen、ベルギー、2820
- 募集
- Imeldaziekenhuis
-
主任研究者:
- Philippe Debruyne, MD
-
-
East-Flanders
-
Aalst、East-Flanders、ベルギー、9300
- 募集
- AZORG vzw and Hartcentrum Aalst
-
主任研究者:
- Tom De Potter, MD
-
-
Hainaut
-
La Louvière、Hainaut、ベルギー、7100
- 募集
- ASBL CHU Helora - Hôpital de La Louvière - site Jolimont
-
主任研究者:
- Antoine de Meester, MD
-
-
Oost-Vlaanderen
-
Ronse、Oost-Vlaanderen、ベルギー、9600
- 募集
- AZ Glorieux
-
主任研究者:
- Becker Alzand, MD
-
-
West-Vlaanderen
-
Bruges、West-Vlaanderen、ベルギー、8000
- 募集
- AZ Sint Jan Brugge AV
-
主任研究者:
- Ian Buysschaert, MD
-
Roeselare、West-Vlaanderen、ベルギー、8800
- 募集
- AZ Delta VZW
-
主任研究者:
- Maarten Vanhaverbeke, MD
-
-
-
-
-
Ustroń、ポーランド、43-450
- 募集
- American Heart of Poland SA
-
主任研究者:
- Krzysztof Milewski, MD
-
-
Masovian Voivodeship
-
Warsaw、Masovian Voivodeship、ポーランド、04-628
- 募集
- Narodowy Instytut Kardiologii Stefana kardynała Wyszyńskiego
-
主任研究者:
- Jerzy Pregowski, MD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- (a) Persistent or permanent atrial fibrillation OR (b) Paroxysmal atrial fibrillation in participants with a history of ischemic stroke or systemic embolism
- Increased risk of stroke, defined as a CHA2DS2-VASc stroke risk score of ≥ 4. [Note: the acronym CHA2DS2-VASc stands for congestive heart failure, hypertension, age ≥75 (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 and sex category (female).]
- Treatment with oral anticoagulants (Vitamin K agonist or factor Xa inhibitor) for at least 90 days prior to enrollment, AND no documented plan to discontinue treatment with oral anticoagulants for the expected duration of the trial.
Exclusion Criteria:
- Age < 18 years
- Current left atrial appendage thrombus
- Prior left atrial appendage occlusion or removal (surgical or percutaneous)
- Prior percutaneous atrial septal defect or patent foramen ovale closure
- Prior atrial fibrillation ablation unless evidence of recurrent qualifying atrial fibrillation present at least 30 days following ablation
- Planned atrial fibrillation ablation within 90 days of enrollment
- Individuals being treated with direct thrombin inhibitors
- Women of childbearing potential unless they agree to employ effective birth control methods throughout the study
- Anticipated life-expectancy of < 2 years
- Patient unable or willing to give informed consent
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:WATCHMAN device
Participants will undergo endovascular left atrial appendage occlusion with the WATCHMAN device |
Participants will undergo endovascular left atrial appendage occlusion with the WATCHMAN device |
|
介入なし:Standard Care
Participants will receive local, standard medical care |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Ischemic stroke or systemic embolism
時間枠:The study duration is event-driven. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
The primary efficacy variable is the time from randomization to first occurrence of any of the components of the composite outcome (adjudicated) over the duration of follow-up, including:
|
The study duration is event-driven. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
All-cause stroke or systemic embolism
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Secondary efficacy outcomes will be evaluated in a hierarchical fashion only when the primary outcome meets statistical significance in the specified order: Time from randomization to first occurrence of all-cause stroke or systemic embolism |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
All-cause stroke, systemic embolism, or transient ischemic attack (TIA)
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Time from randomization to first occurrence of all-cause stroke, systemic embolism or transient ischemic attack (TIA) |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Montreal Cognitive Assessment (MoCA) Score
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Proportion of participants with a decrease of two or more points on the MoCA score at either year 2 or end of study |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
New disabling ischemic strokes
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Time from randomization to first occurrence of disabling ischemic strokes with modified Rankin Score (mRS) >2, measured at 90 days post-stroke |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Cardiovascular mortality
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Time from randomization to cardiovascular mortality |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
All-cause mortality
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Time from randomization to all-cause mortality |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Non-procedural Major Bleeding
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Proportion of participants with non-procedural Major Bleeding (International Society on Thrombosis and Haemostasis (ISTH) definition; excluding WATCHMAN-related bleeding within 14 days of implant) |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Hospitalization for any cause
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Time from randomization to first occurrence of hospitalization for any cause |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Heart failure hospitalization or emergency department/clinic visit for intensification of heart failure related therapy
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Time from randomization to first occurrence of heart failure hospitalization or emergency department/clinic visit for intensification of heart failure related therapy |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Myocardial Infarction
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Time from randomization to first occurrence of Myocardial Infarction (4th Universal definition) |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Device and procedural-related outcomes: Device-related thrombus
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Proportion of participants with device-related thrombus (thrombus formed on the surface of the WATCHMAN device) |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Device and procedural-related outcomes: Incomplete left atrial appendage (LAA) closure
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Proportion of participants with incomplete LAA closure |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
|
Device and procedural-related outcomes: Peri-procedural major bleeding
時間枠:Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
Proportion of participants with peri-procedural major bleeding (ISTH definition; within 14 days following the procedure) |
Will be evaluated once primary outcome meets statistical significance. The primary analysis will be performed through study completion, once 265 primary efficacy endpoint events have occurred (an estimated average follow-up of 4 years).
|
協力者と研究者
捜査官
- 主任研究者:Jeff Healey、Hamilton Health Sciences Corporation
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。